A Clinical Investigation Core is an essential component of a multi- disciplinary HIV research program which fosters translational research through collaboration between clinical and basic scientists. Observations made in the basic science laboratory may merit validation and hypothesis may warrant testing with well characterized clinical specimens from HIV- infected patients. Diagnostic assays which are often developed from laboratory strains of organisms require evaluation with clinical isolates. Some translational research questions can be adequately addressed through analysis of stored specimens, but many require the prospective collection of fresh blood in select populations and specialized processing which is optimally coordinated and conducted by an experienced set of investigators and staff. The objective of the Clinical Investigation Core is to provide access of HIV patient specimens and clinical trials expertise to laboratory and clinical scientists studying HIV pathogenesis and associated opportunistic infections. A secondary objective of the Core is to provide access of specimens to investigators developing diagnostic assays for patient recruitment services including outreach to women, minorities and infection drug users, b) consultation on study design and analysis, c) acquisition of clinical specimens, and d) data entry and collection. The Clinical Investigation Core will promoter AIDS translational research by offering expert consultation by experiencing clinical investigators at an established HIV clinical research unit and access to participants in vaccine, anti-retroviral immune modulator, HIV primary infection, and opportunistic infection protocols. The Core will also permit the use of an established and experienced clinical research unit to obtain and distribute specimens for laboratory based research. The proposed Clinical Investigation Core will provide new opportunities for HIV investigators to study pathogenesis of HIV and associated infections.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
La Jolla
United States
Zip Code
Martin, Thomas C S; Rauch, Andri; Salazar-Vizcaya, Luisa et al. (2018) Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men. Infect Dis Clin North Am 32:395-405
Eren, Kemal; Murrell, Ben (2018) RIFRAF: a frame-resolving consensus algorithm. Bioinformatics 34:3817-3824
de Almeida, Sérgio Monteiro; Ribeiro, Clea E; Rotta, Indianara et al. (2018) Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C. J Neurovirol 24:28-40
Lim, Aaron G; Qureshi, Huma; Mahmood, Hassan et al. (2018) Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination. Int J Epidemiol 47:550-560
Jenks, Jeffrey D; Hoenigl, Martin (2018) Treatment of Aspergillosis. J Fungi (Basel) 4:
Stecher, M; Chaillon, A; Eis-Hübinger, A M et al. (2018) Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, Germany. Clin Microbiol Infect :
Lin, Timothy C; Burton, Brittany N; Barleben, Andrew et al. (2018) Association of HIV infection with age and symptomatic carotid atherosclerotic disease at the time of carotid intervention in the United States. Vasc Med 23:467-475
Singh, Rajendra; Stoneham, Charlotte; Lim, Christopher et al. (2018) Phosphoserine acidic cluster motifs bind distinct basic regions on the ? subunits of clathrin adaptor protein complexes. J Biol Chem 293:15678-15690
Guise, Andy; Melo, Jason; Mittal, Maria Luisa et al. (2018) A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Int J Drug Policy 55:51-60
Bekker, Linda-Gail; Alleyne, George; Baral, Stefan et al. (2018) Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet 392:312-358

Showing the most recent 10 out of 921 publications